Literature DB >> 35118312

Autogenous pericardial angioplasty for thymic malignancies: a narrative review.

Hui-Jiang Gao1, Guo-Dong Shi1, Mao-Jie Pan2, Xiao-Tong Liu1, Yu-Cheng Wei1.   

Abstract

Locally advanced thymic tumor usually invades adjacent great vessels, while the optimal treatment strategy for vessels resection and prosthetic replacement is still in controversial. We hereby present our series of patients undergoing autologous pericardial angioplasty for thymic malignancies. For invasive thymic tumors involving the superior vena cava (SVC), the replacement vessel was prepared by autologous pericardium and placed between the right atrium and distal left innominate vein stump to establish a SVC bypass. Then, the distal right innominate vein and proximal SVC were blocked, and the thymic tumor and involved vessel were completely resected, followed by SVC reconstruction using pericardium. We retrospectively analyzed the clinical characteristics and short-term outcomes of six related patients with autologous pericardial angioplasty. Due to the homologous advantages of autologous pericardial transplantation, those patients didn't need to receive anticoagulant therapy during the perioperative period, so as to avoid the occurrence of hemorrhage, embolism and other graft-related complications. There were no postoperative long-term thoracic drainage (>7 days), anastomotic bleeding, reconstructed vascular stenosis, embolism or even secondary thoracotomy and other related complications occurred in this case series. The application of autologous pericardium for the replacement of mediastinal great vessels in the surgery of locally advanced thymoma is a safe and effective technique. Compared with former artificial materials, such as polytetrafluoroethylene synthetic prosthesis, autologous pericardial transplantation avoids the occurrence of high risk graft-related complications such as postoperative hemorrhage and vascular stenosis, and its clinical application prospect is worth expecting. 2021 Mediastinum. All rights reserved.

Entities:  

Keywords:  Thymic tumor; angioplasty; autologous pericardial transplantation; prognosis; superior vena cava (SVC)

Year:  2021        PMID: 35118312      PMCID: PMC8794382          DOI: 10.21037/med-20-57

Source DB:  PubMed          Journal:  Mediastinum        ISSN: 2522-6711


Introduction

Thymic epithelial tumor (TET) is a rare tumor mostly located in the anterior mediastinum with comparatively good prognosis (1). However, thymoma still has the ability to invade neighboring organs, such as superior vena cava (SVC) and innominate veins. Thymic tumors involving the adjacent great vessels are III-IV stage thymic malignancies, and the prognosis for those diseases is poor after conservative treatment (2). Therefore, locally advanced thymic tumors infiltrating mediastinum great vessels, when radically resectable, can be surgically performed by vessels prosthetic replacement within a multimodality therapeutic approach (3). Many materials have been widely reported for the reconstruction of mediastinal vessels, while the optimal treatment strategy for vessels resection and prosthetic replacement is still in controversial (4-6). Nowadays, the polytetrafluoroethylene (PTFE) and bovine pericardial conduit are mainly used artificial vessels for SVC prosthetic replacement (7,8). Although the application of artificial conduit has expanded the surgical indications for invasive thymic tumors, the biological characteristics of immune rejection must be noticed after vascular conduit reconstruction. In this study, we tried to use autologous pericardial graft for SVC and left innominate vein-right atrium by-pass reconstruction in the surgery of locally advanced thymic tumours, in order to reduce the graft-related complications compared with heterologous conduits. We here report the results of our experience in thymic malignancies en bloc radical resection with conduit reconstruction, and to analyze the short-term outcomes of this extended surgery. We present the following article in accordance with the Narrative Review reporting checklist (available at http://dx.doi.org/10.21037/med-20-57).

Population

The diagnosis of thymic malignancies with mediastinal great vessels involvement mainly depends on imaging inspections such as computed tomography (CT) and magnetic resonance imaging (MRI). CT scan (especially chest dynamic enhanced CT) and MRI can clearly show the location and type of malignant thymoma invasion of the SVC and other neighboring organs (), which is an important indication for tumor radically resectable and surgical procedures. Fludeoxyglucose positron emission tomography (FDG-PET) was performed before surgery for patients with suspected metastatic lesions found at CT-scan (9). The clinical and pathological characteristics of our case series were shown in .
Figure 1

Perioperative imaging of thymic tumor. (A) Dynamic enhanced CT scan shows tumor involved the left innominate vein; (B) thymic malignancies invade superior vena cava, with morphological changes in the adjacent mediastinal great vessels.

Table 1

Clinical and pathological characteristics of six patients

Patient No.SexAge (years)TumorTreatmentResponse after inductionHistologyStage
1M40Thymic carcinomanCT + S + CRTSDSCCIVB
2M48Thymic carcinomanCT + S + RTPRSCCIII
3F37ThymomanCRT + S + RTPRB3 thymomaIII
4M60ThymomanCT + S + CRTSDB2 thymomaIII
5F58Thymic carcinomanCT + S + CRTSDSmall round cellIII
6M62ThymomanCT + S + RTPRB3 thymomaIII

F, female; M, male; CRT, chemoradiotherapy; S, surgery; CT, chemotherapy; RT, radiotherapy; PR, partial response; SD, stable disease; SCC, squamous cell carcinoma.

Perioperative imaging of thymic tumor. (A) Dynamic enhanced CT scan shows tumor involved the left innominate vein; (B) thymic malignancies invade superior vena cava, with morphological changes in the adjacent mediastinal great vessels. F, female; M, male; CRT, chemoradiotherapy; S, surgery; CT, chemotherapy; RT, radiotherapy; PR, partial response; SD, stable disease; SCC, squamous cell carcinoma.

Operative techniques

All the surgeries were performed through a median sternotomy. Indication for circumferential caval resection and conduit reconstruction was established when the tumour infiltrated more than 30% of the vessel circumference (10). After general anesthesia, the patients were placed in the supine position. Afterwards, the sternum was spread to explore the tumor location, infiltrating situation of the SVC and other adjacent organs. Then, the tumor-infiltrated pericardium was resected and the normal pericardial patch was prepared as large as possible. Meanwhile, the pericardial segment of SVC, left and right innominate veins were fully dissected (). Measuring the distance between the left innominate vein without tumor involvement and the auricula dextra cordis, then using autologous pericardium to make an artificial great vessel conduit (). The pericardium is opened as close to the hilum as possible in an attempt to avoid prosthetic patch repair of a large pericardial defect, but the opening must be generous enough to provide adequate exposure of the atrium and proximal cava. The vascular forcep was used to clamp the distal end of the left innominate vein, and the curved auricle clamp was also used to clamp part of the auricula dextra cordis. The left innominate vein-right atrium by-pass was built by autologous pericardial conduit, which sutured with 5-0 Polypropylene (). The thymic tumor and infiltrated vessels were radically resectred after blocking the distal right innominate vein and pericardial segment of SVC (). The autologous pericardium was used to reconstruct the SVC lateral wall or replacement SVC (basing on the degree of SVC tumor involvement) by 5-0 Polypropylene (). Before the final two stitches, opening the right innominate vein forceps and expelling the air in reconstructed vessels. Afterwards, the proximal vascular graft anastomosis is completed, making sure there is no anastomotic stenosis or anastomotic fistula ().
Figure 2

Intra-operative view. (A) Spreading the sternum and exploring the thymic tumor location, infiltrating situation of the adjacent organs; (B) the autologous pericardium was used to make an artificial great vessel conduit; (C) the left innominate vein-right atrium by-pass was built by autologous pericardial conduit, which sutured with 5-0 Polypropylene; (D) the thymic tumor and infiltrated vessels were radically resectred after blocking the related vessels; (E) the autologous pericardium was used to reconstruct the SVC lateral wall by 5-0 Polypropylene; (F) checking the anastomotic stenosis and anastomotic fistula after vascular graft reconstruction.

Intra-operative view. (A) Spreading the sternum and exploring the thymic tumor location, infiltrating situation of the adjacent organs; (B) the autologous pericardium was used to make an artificial great vessel conduit; (C) the left innominate vein-right atrium by-pass was built by autologous pericardial conduit, which sutured with 5-0 Polypropylene; (D) the thymic tumor and infiltrated vessels were radically resectred after blocking the related vessels; (E) the autologous pericardium was used to reconstruct the SVC lateral wall by 5-0 Polypropylene; (F) checking the anastomotic stenosis and anastomotic fistula after vascular graft reconstruction. In this case series study, all the vessels involved were reconstructed with autologous pericardial grafts. Furthermore, after the autogenous replacement, patients would receive low-weight heparin for 3 days to reduce the risk of thrombosis, without receiving life-long anticoagulation therapy. All the patients had no complications such as long-term postoperative catheterization (>7 days), anastomotic bleeding, revascularization stenosis, embolism, and even unplanned secondary sternotomy (). The patency status of the reconstructed vessels was assessed by CT with volume rendering and contrast medium concurrently with the planned oncologic check ().
Table 2

Postoperative outcomes of the entire cohort

Complications descriptionValue
Duration of surgery (min), median [range]192 [165–280]
Perioperative blood loss (mL), median [range]105 [50–200]
Length of thoracic drainage stay (days), median [range]4.5 [4–6]
Length of postoperative hospital stay (days), median [range]5.3 [5–7]
Complications, n (%)N/A
Graft patency, n [%]6 [100]
Figure 3

Postoperative imaging of autogenous pericardial angioplasty. (A) The enhanced CT-scan showed that the right innominate vein and superior vena cava were unobstructed (red arrow); (B) autologous pericardial by-pass conduit was applied between the left innominate vein and right atrium, without stenosis and thrombus formation (green arrow).

Postoperative imaging of autogenous pericardial angioplasty. (A) The enhanced CT-scan showed that the right innominate vein and superior vena cava were unobstructed (red arrow); (B) autologous pericardial by-pass conduit was applied between the left innominate vein and right atrium, without stenosis and thrombus formation (green arrow).

Comments

Thymoma is the most common tumor of anterior mediastinum, accounting for 20–25% of all mediastinal tumors and 50% of the anterior mediastinal tumors, of which 20–30% are thymic malignancies with infiltrating the surrounding thoracic structures (11,12). Radical resection of the thymic tumors and infiltrated adjacent organs is an independent risk factor for improving the survival outcomes. However, the mediastinal great vessels must be reconstructed after achieved R0 resection during the operation (13,14). Since the initial experiences, various autologous or heterologous materials for vascular reconstruction have been introduced and proposed. PTFE conduit is the widely used synthetic vascular prosthesis material for mediastinal great vessels replacement (6). However, due to the immune rejection of heterologous prosthesis, patients need a life-long anticoagulant treatment to prevent graft-related stenosis and thrombosis.While there are still some patients with recurrent SVC syndrome due to graft embolism. At the same time, the intravenous sodium heparin administrated before clamping and long-term administrated anticoagulant drugs after PTFE reconstruction has greatly increased the possibility of hemorrhage in the wound surface even stomas. Sun and his colleagues demonstrated that 32% of patients undergoing PTFE prosthesis replacement for thymic tumors required blood transfusion, and 4% of patients received secondary sternotomy for hemostasis due to conduit anastomotic hemorrhage (14). Other conduits including tubularized bovine pericardium, saphenous vein and more recently, porcine pericardium are also selectable graft (15). According to previous studies, the incidence of postoperative graft-related complications for thymic tumor is as high as 50%, which increases the economic and psychological burden of patients to a certain extent (3,16,17). Based on the limited published data, the autologous pericardium has a lower risk of infection and thrombosis in comparison with synthetic materials, and does not need long-term anticoagulation, making it an ideal graft for vascular reconstruction (18-20). However, other previous studies have also shown that the reconstructed conduit is prone to restenosis after surgery, due to lack of effective lumen. Therefore, the best strategy for SVC replacement still remains controversial (6,10). In order to further improve the prognosis of patients with thymic malignancies and reduce the incidence of vascular graft-related complications, our center tried to use autologous pericardium graft for vessel reconstruction. The advantages of histocompatibility avoid the life-long use of anticoagulant drugs such as heparin and warfarin after surgery, thereby reducing the risk of graft-related anastomotic hemorrhage and thrombosis. In this case series, patients underwent related surgery have recovered well during the perioperative period, without graft-related complications. The planned postoperative CT-scan indicated no stenosis and intraluminal thrombosis in the reconstructed vessels. In our center, through reasonable planning of the surgical procedure before and during the operation, the autologous pericardium can meet the reconstruction requirements of the mediastinal vessels in most of the thymic malignancies. At present, we has routinely applied autologous pericardium to reconstruct mediastinal great vessels in patients with locally advanced thymic tumors for radically resection and improved survival outcomes. In conclusion, en bloc radical resection and conduit reconstruction of mediastinal great vessels with autologous pericardium is a safe and effective procedure. Compared with heterologous grafts, autologous pericardial conduit reduces the high-risk complications related to vascular replacement. This technique is a favourite option for thymic malignancies in our experience.
  20 in total

Review 1.  Multidisciplinary treatment of malignant thymoma.

Authors:  Lorenzo Spaggiari; Monica Casiraghi; Juliana Guarize
Journal:  Curr Opin Oncol       Date:  2012-03       Impact factor: 3.645

Review 2.  Surgical approaches for invasive tumors of the anterior mediastinum.

Authors:  Antonio D'Andrilli; Federico Venuta; Erino A Rendina
Journal:  Thorac Surg Clin       Date:  2010-05       Impact factor: 1.750

3.  Superior vena cava resection for lung and mediastinal malignancies: a single-center experience with 70 cases.

Authors:  Lorenzo Spaggiari; Francesco Leo; Giulia Veronesi; Piergiorgio Solli; Domenico Galetta; Brunilda Tatani; Francesco Petrella; Davide Radice
Journal:  Ann Thorac Surg       Date:  2007-01       Impact factor: 4.330

Review 4.  Systemic treatments for thymoma and thymic carcinoma: A systematic review.

Authors:  Thierry Berghmans; Valérie Durieux; Stéphane Holbrechts; Christiane Jungels; Jean-Jacques Lafitte; Anne-Pascale Meert; Luigi Moretti; Sebahat Ocak; Martine Roelandts; Nicolas Girard
Journal:  Lung Cancer       Date:  2018-10-18       Impact factor: 5.705

5.  [Infiltration of the superior vena cava in NSCLC: results of surgical intervention].

Authors:  T Windisch; J R Fischer; A Vega; S Decker; M Held; T P Graeter
Journal:  Pneumologie       Date:  2014-11-06

6.  Surgical treatment of complex malignant anterior mediastinal tumors invading the superior vena cava.

Authors:  Ke-Neng Chen; Shao-Fa Xu; Zhen-Dong Gu; Wei-Min Zhang; Hong Pan; Wen-Zhong Su; Ji-You Li; Guang-Wei Xu
Journal:  World J Surg       Date:  2006-02       Impact factor: 3.352

7.  Superior vena cava resection with prosthetic replacement for non-small cell lung cancer: long-term results of a multicentric study.

Authors:  Lorenzo Spaggiari; Pascal Thomas; Pierre Magdeleinat; Haruhiko Kondo; Gilles Rollet; Jean Francois Regnard; Ryosuke Tsuchiya; Ugo Pastorino
Journal:  Eur J Cardiothorac Surg       Date:  2002-06       Impact factor: 4.191

8.  Predictors of survival in patients with locally advanced thymoma and thymic carcinoma (Masaoka stages III and IVa).

Authors:  Giuseppe Cardillo; Francesco Carleo; Roberto Giunti; Michele Giovanni Lopergolo; Lorenzo Salvadori; Alessia Raffaella De Massimi; Lea Petrella; Massimo Martelli
Journal:  Eur J Cardiothorac Surg       Date:  2009-11-30       Impact factor: 4.191

9.  Results of superior vena cava resection for lung cancer. Analysis of prognostic factors.

Authors:  Lorenzo Spaggiari; Pierre Magdeleinat; Haruhiko Kondo; Pascal Thomas; Maria Elena Leon; Gilles Rollet; Jean Francois Regnard; Ryosuke Tsuchiya; Ugo Pastorino
Journal:  Lung Cancer       Date:  2004-06       Impact factor: 5.705

10.  Surgical treatment for invasive thymoma, especially when the superior vena cava is invaded.

Authors:  K Yagi; T Hirata; T Fukuse; H Yokomise; K Inui; O Ike; H Mizuno; M Aoki; S Hitomi; H Wada
Journal:  Ann Thorac Surg       Date:  1996-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.